Literature DB >> 18058223

Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations.

Zdenek Kleibl1, Ondrej Havranek, Jan Novotny, Petra Kleiblova, Pavel Soucek, Petr Pohlreich.   

Abstract

The CHEK2 gene mutations I157T (c.470T>C) and IVS2+1G>A affecting the forkhead-associated domain (FHA) have been shown to increase the risk of breast cancer development in several populations. We analyzed the CHEK2 gene segment coding for FHA domain in 673 unselected breast cancer patients and 683 controls from the Czech Republic using the denaturant high-performance liquid chromatography. The found frequency of predominant FHA alteration I157T did not differ between breast cancer patients (19/673; 2.82%) and controls (17/683; 2.49%; P=0.71). Besides this mutation we characterized another nine alterations-six located within FHA coding sequence and three occurring in introns 1 or 2). Eight variants occurred once each in patients with breast cancer and two were present in controls. Three alterations found in breast cancer patients were novel missense variants (Y159H, T172A, and L174F) affecting highly conservative residues in FHA domain. Despite the lack of association of I157T mutation with breast cancer development in our population we deduced that the FHA domain is the subject of rare population-specific alterations that might modify risk of various cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18058223     DOI: 10.1007/s10549-007-9838-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort.

Authors:  Aleksander Myszka; Pawel Karpinski; Ryszard Slezak; Halina Czemarmazowicz; Agnieszka Stembalska; Justyna Gil; Izabela Laczmanska; Damian Bednarczyk; Elzbieta Szmida; Maria Malgorzata Sasiadek
Journal:  J Appl Genet       Date:  2010-12-01       Impact factor: 3.240

2.  Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.

Authors:  Muhammad U Rashid; Noor Muhammad; Saima Faisal; Asim Amin; Ute Hamann
Journal:  BMC Cancer       Date:  2013-06-27       Impact factor: 4.430

Review 3.  Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review).

Authors:  Bo-Rim Yi; Kelvin J Choi; Seung U Kim; Kyung-Chul Choi
Journal:  Int J Oncol       Date:  2012-06-20       Impact factor: 5.650

4.  A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland.

Authors:  Aneta Bąk; Hanna Janiszewska; Anna Junkiert-Czarnecka; Marta Heise; Maria Pilarska-Deltow; Ryszard Laskowski; Magdalena Pasińska; Olga Haus
Journal:  Hered Cancer Clin Pract       Date:  2014-04-08       Impact factor: 2.857

5.  Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer.

Authors:  Andreas Rump; Anna Benet-Pages; Steffen Schubert; Jan Dominik Kuhlmann; Ramūnas Janavičius; Eva Macháčková; Lenka Foretová; Zdenek Kleibl; Filip Lhota; Petra Zemankova; Elitza Betcheva-Krajcir; Luisa Mackenroth; Karl Hackmann; Janin Lehmann; Anke Nissen; Nataliya DiDonato; Romy Opitz; Holger Thiele; Karin Kast; Pauline Wimberger; Elke Holinski-Feder; Steffen Emmert; Evelin Schröck; Barbara Klink
Journal:  PLoS Genet       Date:  2016-08-09       Impact factor: 5.917

6.  Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer.

Authors:  Barbara Wappenschmidt; Jan Hauke; Ulrike Faust; Dieter Niederacher; Lisa Wiesmüller; Gunnar Schmidt; Evi Groß; Andrea Gehrig; Christian Sutter; Juliane Ramser; Andreas Rump; Norbert Arnold; Alfons Meindl
Journal:  Geburtshilfe Frauenheilkd       Date:  2020-04-21       Impact factor: 2.915

Review 7.  CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate.

Authors:  Lenka Stolarova; Petra Kleiblova; Marketa Janatova; Jana Soukupova; Petra Zemankova; Libor Macurek; Zdenek Kleibl
Journal:  Cells       Date:  2020-12-12       Impact factor: 6.600

8.  Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma.

Authors:  Ondrej Havranek; Petra Kleiblova; Jan Hojny; Filip Lhota; Pavel Soucek; Marek Trneny; Zdenek Kleibl
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.